Elyxium Wealth’s Edgewise Therapeutics EWTX Stock Holding History

Elyxium Wealth’s Portfolio EWTX Stock Details EWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$46.2K	Buy	+1,139	New	+$48.4K	﹤0.01%	642

Other funds holding EWTX

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Quantum Private Wealth Tampa, Florida $391M AUM 50.76% 1-Year Est. Return

Moody Aldrich Partners Marblehead, Massachusetts $523M AUM 75.24% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

J. Safra Sarasin Holding $7.05B AUM 26.14% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

Connecticut Capital Management Group Milford, Connecticut $125M AUM 22.9% 1-Year Est. Return

Elyxium Wealth's EWTX Position: Q3 2026 in Review

Elyxium Wealth opened a new position in Edgewise Therapeutics (EWTX) in Q3 2026: 1,139 shares worth $46.2K. The stake represents ﹤0.01% of the portfolio and ranks #642 among its holdings.

38 funds tracked by Wall St. Rank hold EWTX as of Q3 2026.

Elyxium Wealth held 1,139 shares of Edgewise Therapeutics worth $46.2K as of Q3 2026.
Edgewise Therapeutics was a new Elyxium Wealth position in Q3 2026.
Edgewise Therapeutics made up ﹤0.01% of Elyxium Wealth's portfolio in Q3 2026, its #642 holding.
38 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q3 2026.

Based on Elyxium Wealth's 13F filing for Q3 2026, filed 27 Oct 2026.